Department of Biomedical Engineering, The University of Texas at Austin, Austin, TX, USA.
Institute for Biomaterials, Drug Delivery, and Regenerative Medicine, The University of Texas at Austin, Austin, TX, USA.
Biomed Microdevices. 2019 Mar 23;21(2):31. doi: 10.1007/s10544-019-0358-0.
Engineered microscale hydrogels have emerged as promising therapeutic approaches for the treatment of various diseases. These microgels find wide application in the biomedical field because of the ease of injectability, controlled release of therapeutics, flexible means of synthesis, associated tunability, and can be engineered as stimuli-responsive. While bulk hydrogels of several length-scale dimensions have been used for over two decades in drug delivery applications, their use as microscale carriers of drug and cell-based therapies is relatively new. Herein, we critically summarize the fundamentals of hydrogels based on their equilibrium and dynamics of their molecular structure, as well as solute diffusion as it relates to drug delivery. In addition, examples of common microgel synthesis techniques are provided. The ability to tune microscale hydrogels to obtain controlled release of therapeutics is discussed, along with microgel considerations for cell encapsulation as it relates to the development of cell-based therapies. We conclude with an outlook on the use of microgels for cell sequencing, and the convergence of the use of microscale hydrogels for drug delivery, cell therapy, and cell sequencing based systems.
工程化微凝胶已成为治疗各种疾病的有前途的治疗方法。这些微凝胶由于可注射性、治疗药物的控制释放、灵活的合成手段、相关的可调性以及可以设计为响应性的特点,在生物医学领域得到了广泛的应用。虽然几种长度尺度的块状水凝胶已经在药物输送应用中使用了二十多年,但它们作为药物和基于细胞的治疗的微尺度载体的使用相对较新。在此,我们根据水凝胶的分子结构的平衡和动力学以及与药物输送相关的溶质扩散来批判性地总结水凝胶的基础知识。此外,还提供了常见微凝胶合成技术的示例。讨论了调节微尺度水凝胶以获得治疗药物控制释放的能力,以及与细胞治疗相关的细胞包封的微凝胶考虑因素。最后,我们展望了微凝胶在细胞测序中的应用,以及微尺度水凝胶在药物输送、细胞治疗和基于细胞测序的系统中的应用融合。